Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancer

  • Benjamin R. Roman
  • , Shivangi Lohia
  • , Nandita Mitra
  • , Marilene B. Wang
  • , Anna M. Pou
  • , F. Christopher Holsinger
  • , David Myssiorek
  • , David Goldenberg
  • , David A. Asch
  • , Judy A. Shea

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Background: Why physicians use surveillance imaging for asymptomatic cancer survivors despite recommendations against this is not known. Methods: Physicians surveilling head and neck cancer survivors were surveyed to determine relationships among attitudes, beliefs, guideline familiarity, and self-reported surveillance positron-emission-tomography/computed-tomography use. Results: Among 459 responses, 79% reported using PET/CT on some asymptomatic patients; 39% reported using PET/CT on more than half of patients. Among attitudes/beliefs, perceived value of surveillance imaging (O.R. 3.57, C.I. 2.42-5.27, P = <.0001) was the strongest predictor of high imaging, including beliefs about outcome (improved survival) and psychological benefits (reassurance, better communication). Twenty-four percent of physicians were unfamiliar with guideline recommendations against routine surveillance imaging. Among physicians with high perceived-value scores, those less familiar with guidelines imaged more (O.R. 3.55, C.I. 1.08-11.67, P =.037). Conclusions: Interventions to decrease routine surveillance PET/CT use for asymptomatic patients must overcome physicians' misperceptions of its value. Education about guidelines may modify the effect of perceived value.

Original languageEnglish (US)
Pages (from-to)974-987
Number of pages14
JournalHead and Neck
Volume42
Issue number5
DOIs
StatePublished - May 1 2020

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Fingerprint

Dive into the research topics of 'Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancer'. Together they form a unique fingerprint.

Cite this